Proactive Investors One2One Forum featuring Allocate Software, Immupharma and Lo-Q
You are warmly invited to attend our One2One Investor forum tomorrow, where Allocate Software (LON:ALL) , Immupharma (LON:IMM) , LO-Q (LON:LOQ) will be presenting (click each company for in-depth information).
Allocate Software has advanced against all strategic objectives, highlighting its expansion in to Australia and New Zealand, and increasing its presence in the Nordic region following its acquisition of Time Care AB. The company has landed its first e-Rostering contract award under LPP and eight NHS contracts for MAPS Healthroster. Drug development company
ImmuPharma plc is focused on the creation of medicines aimed at treating serious medical conditions. The company was the winner of the New Economy Pharmaceutical & Healthcare Awards for 2010.
Lo-Q was recently awarded its eleventh contract for a Six Flags theme park in the US and signed its first US contract for Q-Text at Lake Compounce, Connecticut. In February Lo-Q results defied the downturn in theme park sector with 30% jump in pre-tax profits, and the share price rose more than 100% in the last 12 months.
Our investor forums are completely free to attend.
The forum will be hosted at the Chesterfield Mayfair Hotel, and will commence at 6pm. Each company has approximately 30 minutes to give a short presentation and for Q&A. Following the presentations will be a complimentary bar and an assortment of the finest hot & cold canapés, giving you the opportunity to speak with the directors and other investors.
If you have any problems registering or queries please email: action@proactiveinvestors.com
Please register your attendance here and we look forward to seeing you.
| Date | 7:30am Tuesday 11th May, 2010 |
| Location | 35 Charles Street |
| Postcode | W1J 5EB |
| Export to your Calendar | |
About the Author's Event
The One2One Forums are designed to allow investors to interact directly with management. Each company has a 30 minute slot, and after the presentations are complete the directors will also be available to take questions during a free canapé and wine reception. ...read more or visit website »
Disclaimer:
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
Allocate Software plc is engaged in the development, sale and support of workforce management solutions, and the provision of related information technology (IT) services to healthcare, defence, government and commercial customers. The Company’s segment includes Licence, subscription, Support and service. Licence and subscription revenue represents revenue from the sale of non-cancellable software licence agreements and subscriptions associated with that software. Support and service revenue represents revenue from the provision of installation, consulting, training and product support. In August 2011, it acquired Zircadian Holdings Limited. On June 1, 2011 the Company acquired Dynamic Change Limited. On March 1, 2012 the Company acquired the Zircadian Limited. more »
Lo-Q plc is engaged in the development and application of virtual queuing technologies. The Company develops virtual queuing technologies for a theme park or other attraction. The Company designs, installs and operates systems, which allow members of the public to make ride and show reservations when they visit a theme park or other attraction. Its flagship product, VQ is a virtual queuing system for theme parks. Its hand-held units, called Q-bots, are used in theme parks around the world. The Company has overseas operations in the United States, Canada, Italy, Germany, Spain and Australia. more »
ImmuPharma plc is a drug discovery and development company. The Company focuses on developing drugs, based on peptide therapeutics, to treat medical conditions such as autoimmune diseases. The Company has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). As of December 31, 2011, the Company had five drug candidates, such as Lupuzor to treat lupus; IPP-204106, to treat cancer; IPP-201007 to treat inflammation/allergic conditions, such as asthma and rheumatoid arthritis; IPP-102199 to treat moderate to severe pain, such as cancer and postoperative pain, and IPP-203101to treat severe resistant hospital-acquired infections, such as methicillin-resistant staphylococcus aureus (MRSA). As of March 27, 2012, Lupuzor received approval from the Food and Drug Administration to start a Phase III trial. more »
